TREATMENT OUTCOMES AFTER HIGHLY-PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) OVARIAN STIMULATION AND LUTEAL SUPPORT WITH A NOVEL PROGESTERONE VAGINAL SYSTEM (PVS): SARA TRIAL ANALYSIS